Table of Contents Author Guidelines Submit a Manuscript
Journal of Parasitology Research
Volume 2011, Article ID 243796, 9 pages
http://dx.doi.org/10.1155/2011/243796
Review Article

CD8 T Cells and Toxoplasma gondii: A New Paradigm

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC 20037, USA

Received 31 December 2010; Accepted 10 March 2011

Academic Editor: D. S. Lindsay

Copyright © 2011 Jason P. Gigley et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Williams and M. J. Bevan, “Effector and memory CTL differentiation,” Annual Review of Immunology, vol. 25, pp. 171–192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Mescher, J. M. Curtsinger, P. Agarwal et al., “Signals required for programming effector and memory development by CD8+ T cells,” Immunological Reviews, vol. 211, pp. 81–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. H. Sharpe, “Mechanisms of costimulation,” Immunological Reviews, vol. 229, no. 1, pp. 5–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Frenkel, “Adoptive immunity to intracellular infection,” Journal of Immunology, vol. 98, no. 6, pp. 1309–1319, 1967. View at Google Scholar · View at Scopus
  5. E. R. Pfefferkorn and L. C. Pfefferkorn, “Toxoplasma gondii. Isolation and preliminary characterization of temperature sensitive mutants,” Experimental Parasitology, vol. 39, no. 3, pp. 365–376, 1976. View at Google Scholar · View at Scopus
  6. Y. Suzuki and J. S. Remington, “Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice,” Journal of Immunology, vol. 140, no. 11, pp. 3943–3946, 1988. View at Google Scholar · View at Scopus
  7. Y. Suzuki, M. A. Orellana, R. D. Schreiber, and J. S. Remington, “Interferon-γ: the major mediator of resistance against Toxoplasma gondii,” Science, vol. 240, no. 4851, pp. 516–518, 1988. View at Google Scholar · View at Scopus
  8. I. A. Khan, K. A. Smith, and L. H. Kasper, “Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii,” Journal of Immunology, vol. 141, no. 10, pp. 3600–3605, 1988. View at Google Scholar · View at Scopus
  9. Y. Suzuki and J. S. Remington, “The effect of anti-IFN-γ antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice,” Journal of Immunology, vol. 144, no. 5, pp. 1954–1956, 1990. View at Google Scholar · View at Scopus
  10. B. J. Luft, R. Hafner, A. H. Korzun et al., “Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome,” The New England Journal of Medicine, vol. 329, no. 14, pp. 995–1000, 1993. View at Publisher · View at Google Scholar
  11. J. P. Dubey, “Advances in the life cycle of Toxoplasma gondii,” International Journal for Parasitology, vol. 28, no. 7, pp. 1019–1024, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. L. D. Sibley and D. K. Howe, “Genetic basis of pathogenicity in toxoplasmosis,” Current Topics in Microbiology and Immunology, vol. 219, pp. 3–15, 1996. View at Google Scholar · View at Scopus
  13. M. E. Grigg, S. Bonnefoy, A. B. Hehl, Y. Suzuki, and J. C. Boothroyd, “Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries,” Science, vol. 294, no. 5540, pp. 161–165, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Frazão-Teixeira, N. Sundar, J. P. Dubey, M. E. Grigg, and F. C. R. de Oliveira, “Multi-locus DNA sequencing of Toxoplasma gondii isolated from Brazilian pigs identifies genetically divergent strains,” Veterinary Parasitology, vol. 175, no. 1-2, pp. 33–39, 2011. View at Publisher · View at Google Scholar
  15. J. P. Dubey, C. Rajendran, D. G. C. Costa et al., “New Toxoplasma gondii genotypes isolated from free-range chickens from the Fernando de Noronha, Brazil: unexpected findings,” Journal of Parasitology, vol. 96, no. 4, pp. 709–712, 2010. View at Publisher · View at Google Scholar
  16. A. Mercier, S. Devillard, B. Ngoubangoye et al., “Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon,” PLoS Neglected Tropical Diseases, vol. 4, no. 11, article e876, 2010. View at Publisher · View at Google Scholar
  17. M. Habek, D. Ozretić, K. Žarković, V. Djaković, and Z. Mubrin, “Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis,” Neurological Sciences, vol. 30, no. 1, pp. 45–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Flegr, M. Novotná, A. Fialová, P. Kolbeková, and Z. Gašová, “The influence of RhD phenotype on toxoplasmosis- and age-associated changes in personality profile of blood donors,” Folia Parasitologica, vol. 57, no. 2, pp. 143–150, 2010. View at Google Scholar · View at Scopus
  19. G. N. Holland, “Ocular toxoplasmosis: the influence of patient age,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 2, pp. 351–357, 2009. View at Google Scholar · View at Scopus
  20. R. E. Holliman, “Toxoplasmosis, behaviour and personality,” Journal of Infection, vol. 35, no. 2, pp. 105–110, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Lindová, M. Novotná, J. Havlíček et al., “Gender differences in behavioural changes induced by latent toxoplasmosis,” International Journal for Parasitology, vol. 36, no. 14, pp. 1485–1492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. Webster, P. H. Lamberton, C. A. Donnelly, and E. F. Torrey, “Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour,” Proceedings of the Royal Society B, vol. 273, no. 1589, pp. 1023–1030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. F. G. Araujo, D. M. Williams, F. C. Grumet, and J. S. Remington, “Strain dependent differences in murine susceptibility to toxoplasma,” Infection and Immunity, vol. 13, no. 5, pp. 1528–1530, 1976. View at Google Scholar · View at Scopus
  24. R. McLeod, P. Eisenhauer, D. Mack, C. Brown, G. Filice, and G. Spitalny, “Immune responses associated with early survival after peroral infection with Toxoplasma gondii,” Journal of Immunology, vol. 142, no. 9, pp. 3247–3255, 1989. View at Google Scholar · View at Scopus
  25. M. Deckert-Schluter, D. Schluter, D. Schmidt, G. Schwendemann, O. D. Wiestler, and H. Hof, “Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response,” Infection and Immunity, vol. 62, no. 1, pp. 221–228, 1994. View at Google Scholar · View at Scopus
  26. C. R. Brown and R. McLeod, “Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection,” Journal of Immunology, vol. 145, no. 10, pp. 3438–3441, 1990. View at Google Scholar · View at Scopus
  27. Y. Suzuki, K. Joh, O. C. Kwon, Q. Yang, F. K. Conley, and J. S. Remington, “MHC class I gene(s) in the D/L region but not the TNF-α gene determines development of toxoplasmic encephalitis in mice,” Journal of Immunology, vol. 153, no. 10, pp. 4649–4654, 1994. View at Google Scholar · View at Scopus
  28. C. R. Brown, C. A. Hunter, R. G. Estes et al., “Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis,” Immunology, vol. 85, no. 3, pp. 419–428, 1995. View at Google Scholar · View at Scopus
  29. C. R. Brown, C. S. David, S. J. Khare, and R. McLeod, “Effects of human class I transgenes on Toxoplasma gondii cyst formation,” Journal of Immunology, vol. 152, no. 9, pp. 4537–4541, 1994. View at Google Scholar · View at Scopus
  30. F. Dzierszinski, M. Pepper, J. S. Stumhofer et al., “Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells,” Infection and Immunity, vol. 75, no. 11, pp. 5200–5209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Teixeiro, M. A. Daniels, S. E. Hamilton et al., “Different T cell receptor signals determine CD8+ memory versus effector development,” Science, vol. 323, no. 5913, pp. 502–505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Zehn, S. Y. Lee, and M. J. Bevan, “Complete but curtailed T-cell response to very low-affinity antigen,” Nature, vol. 458, no. 7235, pp. 211–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Blanchard, F. Gonzalez, M. Schaeffer et al., “Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum,” Nature Immunology, vol. 9, no. 8, pp. 937–944, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. E. M. Frickel, N. Sahoo, J. Hopp et al., “Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes,” Journal of Infectious Diseases, vol. 198, no. 11, pp. 1625–1633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. D. C. Wilson, G. M. Grotenbreg, K. Liu et al., “Differential regulation of effector- and central-memory responses to Toxoplasma gondii infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells,” PLoS Pathogens, vol. 6, no. 3, Article ID e1000815, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Kirak, E. M. Frickel, G. M. Grotenbreg, H. Suh, R. Jaenisch, and H. L. Ploegh, “Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT,” Science, vol. 328, no. 5975, pp. 243–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Galea, M. Bernardes-Silva, P. A. Forse, N. Van Rooijen, R. S. Liblau, and V. H. Perry, “An antigen-specific pathway for CD8+ T cells across the blood-brain barrier,” Journal of Experimental Medicine, vol. 204, no. 9, pp. 2023–2030, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. R. J. Greenwald, G. J. Freeman, and A. H. Sharpe, “The B7 family revisited,” Annual Review of Immunology, vol. 23, pp. 515–548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Keir, M. J. Butte, G. J. Freeman, and A. H. Sharpe, “PD-1 and its ligands in tolerance and immunity,” Annual Review of Immunology, vol. 26, pp. 677–704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C. S. Subauste, R. de Waal Malefyt, and F. Fuh, “Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen,” Journal of Immunology, vol. 160, no. 4, pp. 1831–1840, 1998. View at Google Scholar · View at Scopus
  41. C. S. Subauste, M. Wessendarp, R. U. Sorensen, and L. E. Leiva, “CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer,” Journal of Immunology, vol. 162, no. 11, pp. 6690–6700, 1999. View at Google Scholar · View at Scopus
  42. G. Reichmann, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter, “The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology,” Journal of Immunology, vol. 163, no. 6, pp. 3354–3362, 1999. View at Google Scholar · View at Scopus
  43. E. N. Villegas, M. M. Elloso, G. Reichmann, R. Peach, and C. A. Hunter, “Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii,” Journal of Immunology, vol. 163, no. 6, pp. 3344–3353, 1999. View at Google Scholar · View at Scopus
  44. S. K. Yoshinaga, J. S. Whorlskey, S. D. Khare et al., “T-cell co-stimulation through B7RP-1 and ICOS,” Nature, vol. 402, no. 6763, pp. 827–830, 1999. View at Publisher · View at Google Scholar
  45. E. H. Wilson, C. Zaph, M. Mohrs et al., “B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses,” Journal of Immunology, vol. 177, no. 4, pp. 2365–2372, 2006. View at Google Scholar · View at Scopus
  46. G. Nishanth, M. Sakowicz-Burkiewicz, U. Händel et al., “Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta,” Infection and Immunity, vol. 78, no. 8, pp. 3454–3464, 2010. View at Publisher · View at Google Scholar
  47. T. Yokosuka, W. Kobayashi, K. Sakata-Sogawa et al., “Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C θ translocation,” Immunity, vol. 29, no. 4, pp. 589–601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. T. M. Scharton-Kersten, T. A. Wynn, E. Y. Denkers et al., “In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection,” Journal of Immunology, vol. 157, no. 9, pp. 4045–4054, 1996. View at Google Scholar · View at Scopus
  49. S. K. Bliss, B. A. Butcher, and E. Y. Denkers, “Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection,” Journal of Immunology, vol. 165, no. 8, pp. 4515–4521, 2000. View at Google Scholar · View at Scopus
  50. G. S. Yap and A. Sher, “Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function,” Immunobiology, vol. 201, no. 2, pp. 240–247, 1999. View at Google Scholar · View at Scopus
  51. J. Aliberti, C. Reis e Sousa, M. Schito et al., “CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells,” Nature Immunology, vol. 1, no. 1, pp. 83–87, 2000. View at Google Scholar · View at Scopus
  52. S. K. Bliss, L. C. Gavrilescu, A. Alcaraz, and E. Y. Denkers, “Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology,” Infection and Immunity, vol. 69, no. 8, pp. 4898–4905, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Del Rio, S. Bennouna, J. Salinas, and E. Y. Denkers, “CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection,” Journal of Immunology, vol. 167, no. 11, pp. 6503–6509, 2001. View at Google Scholar · View at Scopus
  54. J. S. Borges and W. D. Johnson, “Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T lymphocyte products,” Journal of Experimental Medicine, vol. 141, no. 2, pp. 483–496, 1975. View at Google Scholar · View at Scopus
  55. J. S. Remington, J. L. Krahenbuhl, and J. W. Mendenhall, “A role for activated macrophages in resistance to infection with Toxoplasma,” Infection and Immunity, vol. 6, no. 5, pp. 829–834, 1972. View at Google Scholar · View at Scopus
  56. C. H. Liu, Y. T. Fan, A. Dias et al., “Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice,” Journal of Immunology, vol. 177, no. 1, pp. 31–35, 2006. View at Google Scholar · View at Scopus
  57. P. M. Robben, M. LaRegina, W. A. Kuziel, and L. D. Sibley, “Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis,” Journal of Experimental Medicine, vol. 201, no. 11, pp. 1761–1769, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. R. T. Gazzinelli, S. Hieny, T. A. Wynn, S. Wolf, and A. Sher, “Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell- deficient hosts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 6115–6119, 1993. View at Google Scholar · View at Scopus
  59. R. T. Gazzinelli, M. Wysocka, S. Hayashi et al., “Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii,” Journal of Immunology, vol. 153, no. 6, pp. 2533–2543, 1994. View at Google Scholar · View at Scopus
  60. I. A. Khan, T. Matsuura, and L. H. Kasper, “Interleukin-12 enhances murine survival against acute toxoplasmosis,” Infection and Immunity, vol. 62, no. 5, pp. 1639–1642, 1994. View at Google Scholar · View at Scopus
  61. G. Yap, M. Pesin, and A. Sher, “Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii,” Journal of Immunology, vol. 165, no. 2, pp. 628–631, 2000. View at Google Scholar · View at Scopus
  62. G. Trinchieri, “Interleukin-12 and the regulation of innate resistance and adaptive immunity,” Nature Reviews Immunology, vol. 3, no. 2, pp. 133–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. A. M. Cooper and S. A. Khader, “IL-12p40: an inherently agonistic cytokine,” Trends in Immunology, vol. 28, no. 1, pp. 33–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Scharton-Kersten, P. Caspar, A. Sher, and E. Y. Denkers, “Toxoplasma gondii: evidence for interleukin-12-dependent and -independent pathways of interferon-γ production induced by an attenuated parasite strain,” Experimental Parasitology, vol. 84, no. 2, pp. 102–114, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. P. M. Robben, D. G. Mordue, S. M. Truscott, K. Takeda, S. Akira, and L. D. Sibley, “Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype,” Journal of Immunology, vol. 172, no. 6, pp. 3686–3694, 2004. View at Google Scholar · View at Scopus
  66. J. P. Gigley, B. A. Fox, and D. J. Bzik, “Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication,” Journal of Immunology, vol. 182, no. 2, pp. 1069–1078, 2009. View at Google Scholar · View at Scopus
  67. E. L. Pearce and H. Shen, “Generation of CD8+ T cell memory is regulated by IL-12,” Journal of Immunology, vol. 179, no. 4, pp. 2074–2081, 2007. View at Google Scholar · View at Scopus
  68. N. S. Joshi, W. Cui, A. Chandele et al., “Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor,” Immunity, vol. 27, no. 2, pp. 281–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. D. C. Wilson, S. Matthews, and G. S. Yap, “IL-12 signaling drives CD8+ T cell IFN-γ production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii infection,” Journal of Immunology, vol. 180, no. 9, pp. 5935–5945, 2008. View at Google Scholar · View at Scopus
  70. T. A. Waldmann, “The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design,” Nature Reviews Immunology, vol. 6, no. 8, pp. 595–601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. I. A. Khan and L. H. Kasper, “IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice,” Journal of Immunology, vol. 157, no. 5, pp. 2103–2108, 1996. View at Google Scholar · View at Scopus
  72. I. A. Khan and L. Casciotti, “IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii,” Journal of Immunology, vol. 163, no. 8, pp. 4503–4509, 1999. View at Google Scholar · View at Scopus
  73. I. A. Khan, M. Moretto, X. Q. Wei, M. Williams, J. D. Schwartzman, and F. Y. Liew, “Treatment with soluble interleukin-15Rα exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response,” Journal of Experimental Medicine, vol. 195, no. 11, pp. 1463–1470, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. L. A. Lieberman, E. N. Villegas, and C. A. Hunter, “Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii,” Infection and Immunity, vol. 72, no. 11, pp. 6729–6732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. C. L. Combe, M. M. Moretto, J. D. Schwartzman, J. P. Gigley, D. J. Bzik, and I. A. Khan, “Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 17, pp. 6635–6640, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Bhadra, H. Guan, and I. A. Khan, “Absence of both IL-7 and IL-15 severely impairs the development of CD8+ T cell response against Toxoplasma gondii,” PLoS ONE, vol. 5, no. 5, article e10842, 2010. View at Publisher · View at Google Scholar
  77. W. Cui and S. M. Kaech, “Generation of effector CD8+ T cells and their conversion to memory T cells,” Immunological Reviews, vol. 236, no. 1, pp. 151–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. R. T. Gazzinelli, F. T. Hakim, S. Hieny, G. M. Shearer, and A. Sher, “Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine,” Journal of Immunology, vol. 146, no. 1, pp. 286–292, 1991. View at Google Scholar · View at Scopus
  79. A. Sher, I. P. Oswald, S. Hieny, and R. T. Gazzinelli, “Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α,” Journal of Immunology, vol. 150, no. 9, pp. 3982–3989, 1993. View at Google Scholar · View at Scopus
  80. H. Kang and Y. Suzuki, “Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain,” Infection and Immunity, vol. 69, no. 5, pp. 2920–2927, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. L. H. Kasper, T. Matsuura, S. Fonseka, J. Arruda, J. Y. Channon, and I. A. Khan, “Induction of γδ T cells during acute murine infection with Toxoplasma gondii,” Journal of Immunology, vol. 157, no. 12, pp. 5521–5527, 1996. View at Google Scholar · View at Scopus
  82. S. D. Sharma, J. R. Catterall, and J. S. Remington, “Parasiticidal activity of macrophages against Toxoplasma,” Methods in Enzymology, vol. 132, pp. 626–637, 1986. View at Google Scholar · View at Scopus
  83. J. S. Remington and T. C. Merigan, “Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii),” Science, vol. 161, no. 3843, pp. 804–806, 1968. View at Google Scholar · View at Scopus
  84. J. L. Krahenbuhl and J. S. Remington, “In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes,” Infection and Immunity, vol. 4, no. 4, pp. 337–343, 1971. View at Google Scholar · View at Scopus
  85. C. F. Nathan, H. W. Murray, M. E. Wiebe, and B. Y. Rubin, “Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity,” Journal of Experimental Medicine, vol. 158, no. 3, pp. 670–689, 1983. View at Google Scholar · View at Scopus
  86. E. R. Pfefferkorn, “Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 3, pp. 908–912, 1984. View at Google Scholar · View at Scopus
  87. H. W. Murray, G. L. Spitalny, and C. F. Nathan, “Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-γ,” Journal of Immunology, vol. 134, no. 3, pp. 1619–1622, 1985. View at Google Scholar · View at Scopus
  88. E. R. Plefferkorn, S. Rebhun, and M. Eckel, “Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts,” Journal of Interferon Research, vol. 6, no. 3, pp. 267–279, 1986. View at Google Scholar · View at Scopus
  89. S. E. Anderson and J. S. Remington, “Effect of normal and activated human macrophages on Toxoplasma gondii,” Journal of Experimental Medicine, vol. 139, no. 5, pp. 1154–1174, 1974. View at Google Scholar · View at Scopus
  90. L. B. Adams, J. B. Hibbs, R. R. Taintor, and J. L. Krahenbuhl, “Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine,” Journal of Immunology, vol. 144, no. 7, pp. 2725–2729, 1990. View at Google Scholar · View at Scopus
  91. B. A. Fox, J. P. Gigley, and D. J. Bzik, “Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation,” International Journal for Parasitology, vol. 34, no. 3, pp. 323–331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. K. A. Jordan, E. H. Wilson, E. D. Tait et al., “Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii,” Infection and Immunity, vol. 77, no. 9, pp. 3894–3901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Gazzinelli, Y. Xu, S. Hieny, A. Cheever, and A. Sher, “Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii,” Journal of Immunology, vol. 149, no. 1, pp. 175–180, 1992. View at Google Scholar · View at Scopus
  94. B. A. Fox and D. J. Bzik, “De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii,” Nature, vol. 415, no. 6874, pp. 926–929, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. C. T. Weaver, L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy, “Th17: an effector CD4 T cell lineage with regulatory T cell ties,” Immunity, vol. 24, no. 6, pp. 677–688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. V. P. Badovinac and J. T. Harty, “Detection and analysis of antigen-specific CD8+ T cells,” Immunologic Research, vol. 24, no. 3, pp. 325–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. L. D. Sibley, L. B. Adams, Y. Fukutomi, and J. L. Krahenbuhl, “Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages,” Journal of Immunology, vol. 147, no. 7, pp. 2340–2345, 1991. View at Google Scholar · View at Scopus
  98. L. L. Johnson, “A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection,” Infection and Immunity, vol. 60, no. 5, pp. 1979–1983, 1992. View at Google Scholar · View at Scopus
  99. R. T. Gazzinelli, I. Eltoum, T. A. Wynn, and A. Sher, “Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation,” Journal of Immunology, vol. 151, no. 7, pp. 3672–3681, 1993. View at Google Scholar · View at Scopus
  100. C. A. Hunter, J. S. Abrams, M. H. Beaman, and J. S. Remington, “Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii,” Infection and Immunity, vol. 61, no. 10, pp. 4038–4044, 1993. View at Google Scholar · View at Scopus
  101. G. S. Yap and A. Sher, “Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α- dependent host resistance to the intracellular pathogen, Toxoplasma gondii,” Journal of Experimental Medicine, vol. 189, no. 7, pp. 1083–1091, 1999. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. Suzuki, H. Kang, S. Parmley, S. Lim, and D. Park, “Induction of tumor necrosis factor-α and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-γ in genetically resistant BALB/c mice,” Microbes and Infection, vol. 2, no. 5, pp. 455–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. D. Schlüter, L. Y. Kwok, S. Lütjen et al., “Both lymphotoxin-α and TNF are crucial for control of Toxoplasma gondii in the central nervous system,” Journal of Immunology, vol. 170, no. 12, pp. 6172–6182, 2003. View at Google Scholar · View at Scopus
  104. F. T. Hakim, R. T. Gazzinelli, E. Denkers, S. Hieny, G. M. Shearer, and A. Sher, “CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells,” Journal of Immunology, vol. 147, no. 7, pp. 2310–2316, 1991. View at Google Scholar · View at Scopus
  105. L. H. Kasper, I. A. Khan, K. H. Ely, R. Buelow, and J. C. Boothroyd, “Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages,” Journal of Immunology, vol. 148, no. 5, pp. 1493–1498, 1992. View at Google Scholar · View at Scopus
  106. J. G. Montoya, K. E. Lowe, C. Clayberger et al., “Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells,” Infection and Immunity, vol. 64, no. 1, pp. 176–181, 1996. View at Google Scholar · View at Scopus
  107. M. B. Purner, R. L. Berens, P. B. Nash et al., “CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans,” Infection and Immunity, vol. 64, no. 10, pp. 4330–4338, 1996. View at Google Scholar · View at Scopus
  108. E. Y. Denkers, G. Yap, T. Scharton-Kersten et al., “Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii,” Journal of Immunology, vol. 159, no. 4, pp. 1903–1908, 1997. View at Google Scholar · View at Scopus
  109. X. Wang, H. Kang, T. Kikuchi, and Y. Suzuki, “Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease,” Infection and Immunity, vol. 72, no. 8, pp. 4432–4438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. Suzuki, X. Wang, B. S. Jortner et al., “Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells,” American Journal of Pathology, vol. 176, no. 4, pp. 1607–1613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. E. D. Tait, K. A. Jordan, C. D. Dupont et al., “Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells,” Journal of Immunology, vol. 185, no. 3, pp. 1502–1512, 2010. View at Publisher · View at Google Scholar
  112. L. Casciotti, K. H. Ely, M. E. Williams, and I. A. Khan, “CD8+-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4+ T cells,” Infection and Immunity, vol. 70, no. 2, pp. 434–443, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. J. C. Sun and M. J. Bevan, “Defective CD8+ T cell memory following acute infection without CD4+ T cell help,” Science, vol. 300, no. 5617, pp. 339–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  114. D. J. Shedlock and H. Shen, “Requirement for CD4+ T cell help in generating functional CD8+ T cell memory,” Science, vol. 300, no. 5617, pp. 337–339, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. E. J. Wherry, S. J. Ha, S. M. Kaech et al., “Molecular signature of CD8+ T cell exhaustion during chronic viral infection,” Immunity, vol. 27, no. 4, pp. 670–684, 2007. View at Publisher · View at Google Scholar · View at Scopus